China&39;s most demanding infant formula regulation/market access requirement to date i.e. its new formula registration policy was made a mandatory requirement on Jan 1st 2018 after an extended grace period. The regulation stipulates that each manufacturing facility can only mferro-time 325 mgarket 3 product lines in Chiferrous sulfate use in pregnancyna. Under tferrous fumarate 210mg tabletshis regulatory environment, infant formula enterprises are exploring new ways to increase their competitiveness and garner traction amongst China’s increasingly discerning consumers. Duringferrous pyrophosphate other name the Food &ferrous sulfate liquid dosingamp;Beverage Innovation Forum 2018 (FBIF 2018) held in Shanghai from 4.18-4.20.2018, Zhu Hong (general manager of R&D center) from Junlebao Dairy Group and Xie Qinggang (R&D manager) from Feihe Dairy shared their opinions on how to realize infant formula innovation in China.
Infant Formula Innovation under China’s New Regulations: Advice from Junlebao and Feihe
